This study provides proof-of-concept of FAP-targeted PDT in PDAC, and future studies should demonstrate the feasibility in other tumour types and the effects on tumour growth, immunomodulation, and efficacy of other systemic therapies. This evidence concerns the gene FAP and neoplasm.